Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study).

导出原文传递

翻译打印收藏纠错

作者： Rita,Ehrlich ^[1] ; Russell,Pokroy ^[2] ; Ori,Segal ^[2] ; Michaella,Goldstein ^[3] ; Ayala,Pollack ^[2] ; Joel,Hanhart ^[4] ; Yoreh,Barak ^[2] ; Rinat,Kehat ^[5] ; Shiri,Shulman ^[6] ; Orit,Vidne ^[7] ; Wiessam,Abu Ahmad ^[8] ; Itay,Chowers ^[9]

作者单位： 1 Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel. ^[1] 2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ^[2] 3 Department of Ophthalmology, Assaf Harofeh Medical Center, Be'er Ya'akov, Israel. ^[3] 4 Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel. ^[4] 5 Department of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel. ^[5] 6 Department of Ophthalmology, Kaplan Medical Center, Rehovot, Israel. ^[6] 7 Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem, Israel. ^[7] 8 Department of Ophthalmology, Rambam Medical Center, Haifa, Israel. ^[8] 9 Department of Ophthalmology, Bnai Zion Medical Center, Haifa, Israel. ^[9] 10 Ophthalmology Institute, Assuta Medical Center, Tel Aviv, Israel. ^[10] 11 Department of Ophthalmology, Sheba Medical Center, Tel Hashomer, Israel. ^[11] 12 Hebrew University-Hadassah Braun School of Public Health and Community Medicine, Jerusalem, Israel. ^[12] 13 Department of Ophthalmology, Hadassah-Hebrew University Medical Center and the Hebrew University Faculty of Medicine, Jerusalem, Israel. ^[13]

关键词 Diabetic macular edema anti-vascular endothelial growth factor bevacizumab intravitreal ranibizumab